How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull ' s-eye In Obesity Treatment
said Friday its obesity treatment, Wegovy, reduced symptoms and physical limitations in people whose hearts are failing. But Novo Nordisk stock remained mostly flat. The company tested Wegovy in patients with heart failure with preserved ejection fraction. This means their hearts are failing, but…#novonordisk #mikhailkosiborod #kosiborod #saintluke #kansas #elililly #lly #novo #danish #glp1
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Denmark Health | Eating Disorders & Weight Management | Health | Heart | Heart Failure | Obesity